|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2 Pt 1
|
|
pubmed:dateCreated |
1989-8-25
|
|
pubmed:abstractText |
Effects of a new recombinant human tumor necrosis factor (rTNF-S) on the growth of murine bladder tumor (MBT-2) were studied. The growth of MBT-2 was significantly inhibited by intratumor injection of rTNF-S. Moreover etoposide (VP-16) and hyperthermia at relatively low temperature enhanced the antitumor effect of rTNF-S. Since TNF is considered to have species preference, these observations may be relevant to treatments for human bladder tumor with human TNF.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0022-5347
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
142
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
386-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:2746758-Animals,
pubmed-meshheading:2746758-Carcinoma, Transitional Cell,
pubmed-meshheading:2746758-Combined Modality Therapy,
pubmed-meshheading:2746758-Etoposide,
pubmed-meshheading:2746758-Female,
pubmed-meshheading:2746758-Humans,
pubmed-meshheading:2746758-Hyperthermia, Induced,
pubmed-meshheading:2746758-Immunotherapy,
pubmed-meshheading:2746758-Mice,
pubmed-meshheading:2746758-Mice, Inbred C3H,
pubmed-meshheading:2746758-Recombinant Proteins,
pubmed-meshheading:2746758-Species Specificity,
pubmed-meshheading:2746758-Tumor Necrosis Factor-alpha,
pubmed-meshheading:2746758-Urinary Bladder Neoplasms
|
|
pubmed:year |
1989
|
|
pubmed:articleTitle |
Immunochemotherapy for murine bladder tumor with a new human recombinant tumor necrosis factor (rTNF-S), VP-16 and hyperthermia.
|
|
pubmed:affiliation |
Department of Urology, Teikyo University School of Medicine, Tokyo, Japan.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
